By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Stemline Therapeutics, Inc. 

1675 York Avenue
Suite 30-E
New York  New York  10128  U.S.A.
Phone: 212-831-1111 Fax:


SEARCH JOBS








Company News
Stemline (STML) Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association 6/23/2017 8:19:53 AM
Stemline (STML) Reports First Quarter 2017 Financial Results 5/11/2017 12:53:49 PM
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering 2/2/2017 5:41:55 AM
Stemline Therapeutics, Inc. (STML) To Present At The Cowen and Company 36th Annual Health Care Conference 3/3/2016 8:26:39 AM
Stemline Therapeutics, Inc. (STML) To Present At The 18th Annual BIO CEO & Investor Conference 2/4/2016 7:54:50 AM
Stemline Therapeutics, Inc. (STML) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/5/2016 8:29:53 AM
Stemline Therapeutics, Inc. (STML) Presents Clinical Update From Ongoing SL-401 Pivotal BPDCN Trial At The American Society of Hematology Annual Meeting 12/8/2015 11:26:08 AM
Stemline Therapeutics, Inc. (STML) Announces Five Presentations, Including SL-401 Clinical Update From Ongoing Pivotal BPDCN Trial, At The Upcoming American Society of Hematology Annual Meeting 12/4/2015 7:46:46 AM
Stemline Therapeutics, Inc. (STML) To Present At The Oppenheimer 26th Annual Healthcare Conference 12/3/2015 8:48:35 AM
Stemline Therapeutics, Inc. (STML) Reports Third Quarter 2015 Financial Results 11/6/2015 7:08:21 AM
12345678910
//-->